Lu-yan Shen
Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The identification of the ATR inhibitor VE-822 as a therapeutic strategy for enhancing cisplatin chemosensitivity in esophageal squamous cell carcinoma.
Journal: Cancer letters
Published: February 24, 2018
P21, COX-2, and E-cadherin are potential prognostic factors for esophageal squamous cell carcinoma.
Journal: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus
Published: November 22, 2016
Possible prediction of the response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy based on gene expression profiling.
Journal: Oncotarget
Published: August 27, 2015
Deregulated HOXB7 Expression Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma and Regulates Cancer Cell Proliferation In Vitro and In Vivo.
Journal: PloS one
Published: January 27, 2015
Coexpression of ANXA2, SOD2 and HOXA13 predicts poor prognosis of esophageal squamous cell carcinoma.
Journal: Oncology reports
Published: January 07, 2014
The survival predictive significance of HOXC6 and HOXC8 in esophageal squamous cell carcinoma.
Journal: The Journal of surgical research
Published: October 09, 2013
Research progress of prognostic protein biomarkers associated with esophagus squamous cell carcinoma
Research progress of prognostic protein biomarkers associated with esophagus squamous cell carcinoma
Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
Published: September 20, 2012
Outcome after surgery preserving pharynx and larynx for cervical esophageal cancer
Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
Published: January 31, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026